Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial - Concepedia

Concepedia

Publication | Open Access

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

DOI Full Paper Access

24

Citations

33

References

2014

Year

Xiaoping Xing, Yan Jiang, Zhenlin Zhang, Zhonglan Zhang, Han-min Zhu, Yiyong Wu, Qun Cheng, Fengli Wu, Jianli Liu, Wei Yu,

Clinical Interventions in Aging

Abstract

Menatetrenone is an effective and safe choice in the treatment of postmenopausal osteoporosis in Chinese women.

References

	Year	Citations

Page 1